|
| Reference | Exposure route | ENMs considered | Study focus |
|
| Morgan [21] | NA | — | Development of preliminary framework for risk analysis and risk management of ENMs using expert elicitation and mental modelling |
|
| Maynard and Kuempel [2] | Inhalation | — | Review of airborne nanostructured particles and occupational health |
|
| Wiesner et al. [22] | NA | — | Assessment of risks of manufactured nanomaterials |
|
| Tsuji et al. [23] | Inhalation and dermal | — | Review of risk assessment of ENMs due to inhalation and dermal routes |
|
| Lam et al. [10] | Inhalation | Carbon nanotubes | Review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks |
|
| Kandlikar et al. [24] | Inhalation | Particles less than 2.5 m in diameter | Health risk assessment of nanoparticles using expert judgment |
|
| Dankovic et al. [11] | Inhalation | Fine and ultrafine TiO2 | Calculation of risk of cancer using dose-response information for rats |
|
| Mueller and Nowack [3] | NA | Ag, TiO2, and carbon nanotubes | Exposure modelling of ENMs in environment using life-cycle perspectives |
|
| Liao et al. [12] | Inhalation | Nano-/fine TiO2 | Model-based assessment for human inhalation exposure risk assessment |
|
| Kroll et al. [25] | NA | — | Current in vitro methods in ENMs risk assessment: limitation and challenges |
|
|
Shinohara et al. [26] | Inhalation | Fullerenes | Risk assessment |
|
| Morimoto et al. [27] | Inhalation | Fullerenes | Inflammogenic effect of well-characterised fullerenes in inhalation and intratracheal instillation studies |
|
| Tervonen et al. [28] | NA | Fullerenes, carbon nanotubes,
CdSe, Ag, and Al | Risk-based classification systems of nanomaterials |
|
| O’Brien and Cummins [29] | NA | NA | Development of a three-level risk assessment strategy for nanomaterials |
|
| Grieger et al. [30] | NA | — | Study of current research priorities for nanomaterials and redefining of risk-based efforts |
|
| Christensen et al. [31] | Inhalation | Ag | Investigation of feasibility and challenges associated with conducting HHRA for Ag ENMs and identification of related data gaps |
|
| Christensen et al. [32] | Inhalation | TiO2 | Investigation of feasibility and challenges associated with conducting HHRA for TiO2 ENMs and identification of related data gaps |
|
|
Gangwal et al. [33] | Inhalation | TiO2 and Ag | Method development for determining nanomaterials concentrations for ToxCast in vitro testing for occupational exposure potential |
|
|
Anandan and Kumar [34] | Oral | TiO2 and Ag | Estimation of risk to humans due to exposure of ENMs during inadvertent ingestion of stream water using liver cell line-based toxicity data |
|
| Johnson et al. [35] | Oral | TiO2 | Study on fate, behaviour, and environmental risk associated with sunscreen TiO2 ENMs; HHRA conducted for ingestion of TiO2 particles |
|
| Kumar et al. [36] | Inhalation | ENMs | Emissions estimates of nanomaterials from road vehicles in megacity Delhi and associated health impacts |
|
| Kumar [37] | NA | ENMs | Making a case for human health risk-based ranking nanomaterials in water for monitoring purposes |
|
| Kumar et al. [38] | NA | ENMs | Known, unknowns, and awareness related to nanomaterials in Indian environment |
|
| Singh and Kumar [39] | NA | ENMs | Identifying knowledge gaps in assessing health risks due to exposure of nanoparticles from contaminated edible plants |
|
| Khanna and Kumar [40] | NA | ENMs | Including nanomaterials mixtures in human health risk assessment |
|
|
Frater et al. [41] | NA | ENMs | A multistakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment |
|
| Savolainen et al. [42] | NA | ENMs | Nanosafety in Europe 2015–2025: towards safe and sustainable nanomaterials and nanotechnology innovations |
|
| Stone et al. [43] | NA | ENMs | Prioritising nanosafety research to develop a stakeholder-driven intelligent testing strategy |
|
